Palantir Technologies Inc. v. Abramowitz

Opinion

1 2 3 UNITED STATES DISTRICT COURT 4 NORTHERN DISTRICT OF CALIFORNIA 5 SAN JOSE DIVISION 6 7 PALANTIR TECHNOLOGIES INC., Case No. 19-cv-06879-BLF

8 Plaintiff, ORDER ON MOTIONS IN LIMINE 9 v. [Re: ECF No. 356-63, 365, 366] 10 MARC L. ABRAMOWITZ, 11 Defendant.

12 13 In preparation for trial the Court held the Final Pretrial Conference in this case on October 14 13, 2022, during which the Court issued oral rulings on the parties’ motions in limine. See 15 Motions, ECF Nos. 356-63, 365, 366. The Court’s rulings on the parties’ motions in limine are set 16 forth as follows. 17 I. PLAINTIFF’S MOTIONS IN LIMINE 18 A. Plaintiff’s Motion in Limine No. 1 to Exclude Evidence Regarding the i2 Litigation 19 Palantir seeks to exclude evidence regarding i2, Inc. et al v. Palantir Technologies, Inc., 20 No. 1:10-cv-0085-LO-JFA (E.D. Va.) (the “i2 Litigation”), in which i2 Inc. sued Palantir for, 21 among other things, trade secret misappropriation and breach of contract. See Pl.’s MIL No. 1, at 22 1, ECF No. 361. Palantir argues that evidence or argument pertaining to the i2 Litigation should 23 be excluded from trial under Federal Rule of Evidence 403 because it is irrelevant and will cause 24 Palantir unfair prejudice. Id. at 1-3. Palantir contends that the litigation is irrelevant because it 25 has no connection to Abramowitz or Palantir’s allegations against Abramowitz. Id. at 2. Palantir 26 contends that the litigation would unduly prejudice Palantir because the jury may seek to punish 27 Palantir by meriting unsubstantiated allegations against the company and would force Palantir to 1 waste trial time rebutting the allegations in the i2 Litigation. Id. at 3. 2 Abramowitz responds that evidence regarding the i2 Litigation is admissible under Rule 3 403. Def.’s Opp’n MIL 1, ECF No. 379. Abramowitz argues that the i2 Litigation is relevant 4 because it implicates the credibility of Palantir’s Chief Operating Officer Shyam Sankar—a 5 “critical witness in this case” who allegedly divulged to Abramowitz Palantir’s purported trade 6 secrets concerning “Cyber Technology” during an in-person meeting in June 2014. Id. at 1-4. 7 Abramowitz contends that settlement of the i2 Litigation is probative of bias in Sankar’s testimony 8 because Palantir settled the matter on behalf of itself, Sankar, and Sankar’s father. Id. at 1-3. 9 Abramowitz further argues that the evidence the of the litigation is probative of Sankar’s 10 dishonesty because, at some point after the litigation, Sankar solicited Abramowitz for help getting 11 his father a job without telling Abramowitz about the allegations against his father. Id. at 3. 12 Abramowitz concedes that presenting evidence of the i2 Litigation at trial will prejudice Palantir 13 but that such prejudice is not undue. Id. at 4. Abramowitz contends that the jury will not draw 14 unfair inferences and Palantir will not have to spend time rebutting the allegations from the 15 i2 Litigation because Sankar has already admitted the facts Abramowitz seeks to present. Id. at 4. 16 The Court has considered the evidence under Federal Rule of Evidence 403. The Court 17 agrees with Abramowitz that aspects of the i2 Litigation, including Palantir’s settlement of the 18 matter on his behalf, are probative of Mr. Sankar’s credibility and bias. The Court finds that, as to 19 Mr. Sankar, evidence about the litigation is unlikely to lead to minitrials, as he has admitted the 20 relevant conduct in deposition. See Def.’s Opp’n MIL 1, Ex. B, ECF No. 378-4. The Court also 21 finds that any unfair prejudice that could arise from discussion of the i2 Litigation can be 22 mitigated with a limiting instruction. Weighing these considerations, the Court finds that the 23 relevance of certain aspects of the i2 Litigation to Mr. Sankar’s credibility and bias is not 24 substantially outweighed by the danger unfair prejudice, confusing the issues, misleading the jury, 25 undue delay, wasting time, or needlessly presenting cumulative evidence. See Fed. R. Evid. 403. Palantir’s motion is therefore DENIED, but the Court will allow a limiting instruction that 26 information concerning the i2 Litigation may be used solely to assess Mr. Sankar’s bias or 27 B. Plaintiff’s Motion in Limine No. 2 to Exclude Evidence Regarding Non- 1 Operative Trade Secret Disclosures 2 Palantir seeks to exclude evidence regarding non-operative trade secret disclosures under 3 Federal Rule of Evidence 403. See Pl.’s MIL No. 2, ECF No. 362. Palantir argues that this 4 evidence is not relevant. Id. at 3-5. Palantir also argues that its presentation will cause unfair 5 prejudice because it will lead the jury to draw prejudicial inferences about Palantir’s reasons for 6 submitting multiple trade secret disclosures and distract the jury from the relevant disclosures. Id. 7 at 4-5. Abramowitz responds that the non-operative trade secret disclosures are relevant because 8 they are probative of the integrity of Palantir’s claims. Def.’s Opp’n MIL No. 2, at 1, ECF No. 9 381. Abramowitz concedes that this evidence is prejudicial to Palantir but contends that any such 10 prejudice is not unfair. Id. at 5. 11 The Court has considered the evidence under Federal Rule of Evidence 403. The Court 12 finds that the superseded trade secret disclosures have little to no relevance. They are documents 13 created for litigation to serve as a gateway to initiating discovery. See Cal. Code Civ. P. 14 § 2019.210; see also Advanced Modular Sputtering, Inc. v. Superior Ct., 132 Cal. App. 4th 826, 15 833-34 (2005) (describing purposes of trade secret disclosures). Furthermore, they are not 16 relevant to the credibility of any representation by Palantir that it owned the alleged trade secrets 17 at the time of the alleged misappropriation, as the disclosures were created after any accused 18 conduct. See BladeRoom Grp. Ltd. v. Facebook, Inc., No. 5:15-CV-01370-EJD, 2018 WL 19 1569703, at *1 (N.D. Cal. Mar. 30, 2018). The Court further finds that presentation of the 20 superseded trade secret disclosures will waste time, as they will require extensive explanation as to 21 why and how they were created and why they were later modified, and even with this explanation 22 may confuse the jury. Weighing these considerations, the Court finds that any probative value of 23 the non-operative trade secret disclosures is substantially outweighed by a danger of confusing the 24 issues, misleading the jury, undue delay, and wasting time. Palantir’s motion is therefore 25 GRANTED. 26 C. Plaintiff’s Motion in Limine No. 3 to Exclude Evidence of Palantir’s Motive for 27 Filing Lawsuit and Delaware Litigation 1 LLC v. Palantir Technologies Inc., No. N17C-12-212 EMD CCLD (Del. Sup. Ct.) (the “Delaware 2 Litigation”), a settled case in which Abramowitz sued Palantir. See Pl.’s MIL No. 3, ECF No. 3 363. Palantir argues that the evidence should be excluded under Federal Rules of Evidence 402 4 and 403. See id. at 1, 3, 5. Palantir argues that any such evidence is irrelevant, will force Palantir 5 to spend time defending itself against the allegations in the Delaware Litigation, lead to jury 6 confusion, and cause Palantir unfair prejudice. Id. at 3-5. 7 Abramowitz responds that he seeks to present evidence related to the Delaware Litigation 8 to show Palantir’s motive for bringing this litigation, to refute Palantir’s claim that it acted 9 diligently to protect its intellectual property as required to prevail on a CUTSA claim, and to show 10 witness bias. See Def.’s Opp’n MIL No. 3, at 1, ECF No. 384. Abramowitz argues that this 11 evidence is relevant because it shows that Palantir declined to protect its purported trade secrets 12 until after Abramowitz initiated the Delaware Litigation. Id. at 3. According to Abramowitz, this 13 shows that Palantir never believed that the alleged trade secrets Abramowitz allegedly 14 misappropriated were in fact trade secrets. Id. Abramowitz also argues that the evidence is 15 relevant to show that Palantir’s witnesses are biased against him for trying to hold Palantir to 16 account for its alleged misconduct. Id. at 4. Finally, Abramowitz argues that this evidence will 17 not result in mini-trials or delay because the existence of the Delaware Litigation complaint and 18 the agreement upon which it is based are undisputed. Id. at 5. 19 The Court has considered the evidence under Federal Rules of Evidence 402 and 403. 20 Motive to sue is irrelevant to any issue in this case. The Court therefore finds that evidence about 21 the Delaware Litigation is inadmissible under Rules 402 and 403 for the purpose of showing 22 Palantir’s motive for bringing this litigation. 23 However, the Court finds that evidence concerning the Delaware Litigation is relevant to 24 Abramowitz’s contention that Palantir delayed in protecting its trade secrets and to potential 25 witness bias. The Court further finds that testimony on this matter limited to these relevant topics 26 will not cause delay or unfair prejudice. Weighing these considerations, the Court finds that the 27 probative value of evidence concerning the Delaware Litigation, as it relates to Palantir’s diligence 1 danger of unfair prejudice, confusing the issues, misleading the jury, undue delay, wasting time, or 2 needlessly presenting cumulative evidence. 3 Palantir’s motion is therefore DENIED, but the Court will limit the presentation of 4 evidence regarding the Delaware Litigation to evidence concerning Palantir’s diligence in 5 protecting its trade secrets and potential witness bias. The Court will not permit the parties to 6 present evidence of the Delaware Litigation to show Palantir’s motive for bringing this action. 7 The Court will address the admissibility of exhibits related to the Delaware Litigation as they are 8 presented at trial; however, the excessively long list of documents listed in the motion would not 9 appear to serve the interests of efficient use of the jury’s time. 10 D. Plaintiff’s Motion in Limine No. 4 to Exclude Hearsay Statements from Defendant’s Patent Counsel 11 Palantir seeks to exclude email conversations between Abramowitz’s patent counsel. See 12 Pl.’s MIL No. 4, ECF No. 365. Palantir argues that these communications are hearsay and 13 therefore inadmissible. Id. at 5. Def.’s Opp’n MIL No. 4, ECF No. 387. Abramowitz argues that 14 the communications are not hearsay because they are not being offered for the truth for the matter 15 asserted; are being offered to show effect on the listener; and are being offered as prior consistent 16 statements. Id. at 2-3. Abramowitz further argues that even if the Court finds that the 17 communications are hearsay, they are admissible under the then-existing-state-of-mind exception. 18 Id. at 3. 19 The Court DEFERS its ruling on Palantir’s motion. The Court will assess the admissibility 20 of the email conversations between Abramowitz’s patent counsel as they are offered at trial, 21 considering the context in which they are offered. However, to date Abramowitz has not 22 suggested a viable non-hearsay purpose for admitting the emails. The Court will maintain an open 23 mind to admissibility at trial. 24 E. Plaintiff’s Motion in Limine No. 5 to Exclude Testimony from Undisclosed 25 Witnesses 26 Palantir seeks to preclude the testimony of David Lawrence under Federal Rule of Civil 27 Procedure 37(c)(1). See Pl.’s MIL No. 5, ECF No. 366. Palantir contends that Abramowitz failed 1 Palantir asserts that this failure was not substantially justified because Abramowitz has known 2 about Mr. Lawrence purported relevance since the outset of the case. Id. at 4. Palantir further 3 asserts that it would be harmed if Mr. Lawrence were permitted testify because Abramowitz’s 4 failure to disclose him deprived Palantir of the opportunity to seek his deposition and take other 5 relevant discovery. Id. at 4. 6 Abramowitz responds to each of Palantir’s arguments. See Def.’s Opp’n MIL No. 5, ECF 7 No. 389. Abramowitz argues that Mr. Lawrence was adequately disclosed in discovery, as 8 Palantir itself disclosed him in its discovery responses as a person who may have received access 9 to Palantir’s trade secrets; Palantir asked about Mr. Lawrence during depositions of Abramowitz 10 and his patent attorneys; and Mr. Lawrences name was listed in produced documents. Id. at 2-3. 11 Abramowitz also argues that any late disclosure was harmless because Palantir knew about Mr. 12 Lawrence. Id. at 4. 13 The Court finds that Abramowitz did not adequately disclose Mr. Lawrence to satisfy its 14 Rule 26 obligations and that Palantir would be harmed if Mr. Lawrence were permitted to testify 15 without recourse to other remedial measures. In the event of a party’s failure to adequately 16 disclose a witness, the Court may to impose appropriate sanctions. Fed. R. Civ. P. 37(c)(1). Here, 17 the Court finds that the proper remedy is to give Palantir an opportunity depose Mr. Lawrence to 18 cure the harm of his late disclosure. Palantir’s motion to exclude Mr. Lawrence’s testimony is 19 therefore DENIED, but Abramowitz must make Mr. Lawrence available for deposition before 20 trial. 21 II. DEFENDANT’S MOTIONS IN LIMINE 22 A. Defendant’s Motion in Limine No. 1 to Exclude Evidence and Argument About 23 Reasonable Royalty from the Jury 24 Abramowitz seeks to exclude evidence and argument about reasonable royalty from the 25 jury. See Def.’s MIL No. 1, ECF No. 356. Abramowitz argues that such evidence is irrelevant 26 and therefore inadmissible to the jury because the plain language of CUTSA reserves for the court 27 the award of a reasonable royalty. Id. Palantir responds that because the action is in federal court, 1 Opp’n MIL No. 1, ECF No. 383. Palantir contends that the Seventh Amendment guarantees trade 2 secret litigants in federal court the opportunity to present reasonable royalty to a jury. Id. at 2. 3 The Court agrees with Palantir that the Seventh Amendment guarantees trade secret 4 litigants in federal court the right to present reasonable royalty to a jury. Under a plain-text 5 reading of CUTSA, the award of a “reasonable royalty” is determined by the court, not the jury. 6 See Cal. Civ. Code § 3426.3(b). But in federal court, state prohibitions on jury trials are irrelevant 7 because federal law and the Seventh Amendment control. See Simler v. Conner, 372 U.S. 221, 8 222 (1963) (“[T]he right to a jury trial in the federal courts is to be determined as a matter of 9 federal law in diversity as well as other actions.”). To determine whether the Seventh Amendment 10 preserves the right to a jury trial on a given action, a court first compares the action to those 18th- 11 century actions brought in the courts of England prior to the merger of the courts of law and equity 12 and then examines the remedy sought to determine whether it is legal or equitable in nature. 13 Granfinanciera, S.A. v. Nordberg, 492 U.S. 33, 41-42 (1989). 14 As to the first step, the Court finds that a CUTSA trade secret action is most analogous to 15 an action that would have been brought at common law. The Court is persuaded by the historical 16 review in De Lage Landen Operational Services, LLC v. Third Pillar Systems, LLC, which 17 identified the earliest recorded trade secret action in the United States or England as occurring in 18 1817. No. CIV.A. 09-2439, 2011 WL 1627899, at *3 (E.D. Pa. Apr. 28, 2011) (identifying 19 Newberry v. James, 35 Eng. Rep. 1011 (Ch. 1817)). The Court therefore looks to analogous 20 actions to determine whether they would have been brought before a court of law or equity in 21 1791. 22 The Court finds persuasive the Federal Circuit’s conclusion that “[f]or Seventh 23 Amendment purposes, claims for patent, copyright, or trademark infringement are appropriate 24 analogues of the trade secret claim here.” Texas Advanced Optoelectronic Sols., Inc. v. Renesas 25 Elecs. Am., Inc., 895 F.3d 1304, 1325 (Fed. Cir. 2018). Patent infringement actions were tried at 26 law in the 18th century. See Markman v. Westview Instruments, Inc., 517 U.S. 370, 377 (1996) as 27 were copyright actions for damages, see Feltner v. Columbia Pictures Television, Inc., 523 U.S. 1 analysis suggests a trade secret claim should be presented to a jury. The Court notes, however, 2 that the issue here is whether a party has a right to a decision by a jury on a particular remedy for 3 trade secret misappropriation. As remedy is the focus of the second step of the analysis, the Court 4 turns to that step noting that it carries additional weight. 5 At the second step of the Seventh Amendment analysis, a court examines the remedy 6 sought to determine whether it is legal or equitable in nature. Granfinanciera, 492 U.S. at 41-42. 7 This stage of this analysis is more important than the first. Id. The Court agrees with the Federal 8 Circuit, which has explained that reasonable royalty is “not restitutional in nature,” but “simply 9 money damages awarded in an action at law.” Injection Rsch. Specialists, Inc. v. Polaris Indus., 10 L.P., No. 97-1516, 1998 WL 536585, at *15 (Fed. Cir. 1998). The Supreme Court has 11 “recognized the ‘general rule’ that monetary relief is legal.” Feltner, 523 U.S. 340 at 352. The 12 Court therefore finds that the second step of the analysis further weighs in favor of finding that a 13 party has a right to have a jury decide reasonable royalty. Accordingly, the Court finds that the 14 Seventh Amendment guarantees federal litigants the right to a jury determination of reasonable 15 royalties under the CUTSA. The Court’s conclusion is consistent with the Court’s holding in De 16 Lage, 2011 WL 1627899, a CUTSA case arising in the Eastern District of Pennsylvania that 17 confronted same issue. Abramowitz’s motion is therefore DENIED. 18 The Court notes that at oral argument on this matter Abramowitz raised an argument not 19 raised in its briefing. Under CUTSA the award of reasonable royalty is available only if neither 20 damages nor unjust enrichment are provable. Cacique, Inc. v. Robert Reiser & Co., 169 F.3d 619, 21 623 (9th Cir. 1999). According to Abramowitz, evidence supporting reasonable royalty therefore 22 may never become relevant if damages or unjust enrichment are provable. 23 As the Court explained at the oral argument, it is sympathetic to Abramowitz’s concern 24 that evidence related to reasonable royalty may never become relevant. The Court is also 25 concerned that the presentation of such evidence may be confusing to the jury or may result in the 26 jury mistakenly awarding a reasonable royalty when damages or unjust enrichment are provable. 27 The Court is therefore inclined to allow the presentation of evidence concerning reasonable 1 Court is further inclined to require that the parties announce the time they are reserving for this 2 issue before the trial. The parties should be prepared to discuss this proposal and their proposed 3 time allotments at the scheduling conference set for November 18, 2022. 4 B. Defendant’s Motion in Limine No. 2 to Exclude Evidence and Argument About Damages from Breach of Contract 5 In its briefing, Abramowitz moved to preclude Palantir “from introducing at trial any 6 evidence or argument related to damages for its contract claim.” Def.’s MIL No. 2, at 1, ECF No. 7 357. Abramowitz argued that Palantir failed to comply with its obligations under Federal Rule of 8 Civil Procedure 26(a)(1)(iii) to produce computations of each category of damages claimed and 9 make available the evidentiary material on which the computations are based. Id. In response 10 Palantir identified the damages theory it disclosed in its initial disclosures and throughout the 11 litigation and noted that it disclosed bills in support of that theory. Pl.’s Opp’n MIL No. 2, at 3-4, 12 ECF No. 385. 13 During oral argument Abramowitz did not dispute that Palantir had adequately disclosed a 14 damages theory for its breach of contract claim. Abramowitz instead modified its request by 15 asking that the Court exclude other theories that Palantir identified in its initial disclosures but, 16 according to Abramowitz, did not adequately disclose in its interrogatory responses or expert 17 discovery. Id. 18 The Court finds that Palantir adequately disclosed the contract damages theory it identified 19 in its briefing. This is sufficient to deny Abramowitz’s overbroad motion requesting that Palantir 20 be precluded from offering “any evidence or argument related to damages for its contract claim.” 21 The Court declines to consider Abramowitz’s alternative request—raised for the first time at oral 22 argument—that Palantir be excluded from presenting evidence or argument on other contract 23 damages theories, as this issue was not briefed and Palantir did not have an adequate opportunity 24 to respond. See, e.g., Makaeff v. Trump Univ., LLC, 2014 WL 2743244, at *4 n.2 (S.D. Cal. June 25 17, 2014) (“the Court need not consider issues raised for the first time during oral argument”). 26 Accordingly, Abramowitz’s motion is DENIED. 27 C. Defendant’s Motion in Limine No. 3 to Exclude References to German Litigation 1 Between Palantir and Mr. Abramowitz 2 Abramowitz requests that the Court preclude Palantir from referencing the German litigation 3 between Palantir and Abramowitz (“German Litigation”) “in any way.” Def.’s MIL No. 3, ECF No. 4 358. Abramowitz contends that any reference to the German Litigation would be irrelevant and 5 unfairly prejudicial and therefore should be excluded under Federal Rules of Evidence 402 and 403. 6 Id. at 3-5. Abramowitz also contends that any references to the German litigation are inadmissible 7 hearsay. Id. at 5. Palantir argues that Abramowitz’s motion is overbroad and that the Court should 8 consider objections to specific evidence on an item-by-item basis. Pl.’s Opp’n MIL No. 3, at 1, ECF 9 No. 386. Palantir also identifies certain aspects of the German Litigation that it argues are admissible. 10 Id. For example, Palantir notes that the German Litigation concerns the same subject matter and 11 parties as the present litigation, and therefore Abramowitz’s statements in the German Litigation may 12 contain relevant party admissions. Id. at 3. Palantir also argues that the existence of a German 13 criminal investigation arising from Abramowitz’s submissions in the German Litigation is relevant to 14 Abramowitz’s credibility, as it may cause him to tailor his testimony to avoid prosecution. Id. at 4-5. 15 The Court finds that Abramowitz’s motion is overbroad. For example, to the extent 16 Abramowitz has made statements in the German Litigation, those statements would likely be 17 admissible if offered by Palantir as opposing party’s statements. Fed. R. Evid. 801(d)(2). 18 Accordingly, Abramowitz’s motion is DENIED. The Court will consider the admissibility of 19 evidence related to the German Litigation as it is offered at trial. 20 The Court notes, however, that it will exclude any mention of the German criminal 21 proceedings. The criminal proceedings remain ongoing, and the jury likely will have little 22 understanding of the German criminal system. Reference to the existence of the German criminal 23 proceedings may unfairly prejudice Abramowitz by causing the jury to improperly infer that 24 Abramowitz has committed the wrongdoing alleged in the present litigation. See United States v. 25 Hankey, 203 F.3d 1160, 1172 (9th Cir. 2000) (“unfair prejudice means ‘undue tendency to suggest 26 decision on an improper basis, commonly, though not necessarily, an emotional one.’” (quoting 27 Fed. R. Evid. 403 advisory committee’s note to 1972 proposed rules)). While the Court agrees 1 credibility, the Court finds that this probative value is substantially outweighed by the danger of 2 unfair prejudice. See Fed. R. Evid. 403. 3 D. Defendant’s Motion in Limine No. 4 to Exclude Evidence and Argument About Mr. Abramowitz's Wealth from the Jury 4 Abramowitz seeks to preclude Palantir from offering evidence regarding his wealth under 5 Federal Rules of Evidence 401, 402, and 403. Def.’s MIL No. 4, ECF No. 359. Abramowitz first 6 contends that any such evidence is irrelevant to the issues in the case and its admission would 7 unfairly prejudice him. Id. at 1-2. Abramowitz then concedes that wealth may be relevant to 8 assessing punitive damages but argues that such evidence should be presented to the Court in a 9 subsequent proceeding only if the jury finds that he acted willfully and maliciously. Id. at 2. 10 Palantir argues that evidence of Abramowitz’s wealth should not be excluded for three 11 reasons: (1) it is probative of Abramowitz’s ability to commercialize the alleged trade secrets and 12 therefore pay a reasonable royalty to license the alleged trade secrets; (2) it is relevant to punitive 13 damages, which must be presented to a jury under the Seventh Amendment; and (3) Abramowitz’s 14 ownership interest in Palantir is probative of whether Palantir adequately protected its trade secrets 15 when it shared them with Abramowitz. Pl.’s Opp’n MIL No. 4, at 1, ECF No. 388. 16 The Court finds that evidence of Abramowitz’s wealth is admissible because it is relevant 17 to and highly probative of the reasonable royalty analysis, circumstances under which Palantir 18 entrusted Abramowitz with its confidential information, and exemplary damages. Admission of 19 this evidence does not create a danger of unfair prejudice, confusing the issues, misleading the 20 jury, undue delay, wasting time, or needlessly presenting cumulative evidence. See Fed. R. Evid. 21 403. 22 In regard to punitive damages, under CUTSA, “[i]f willful and malicious misappropriation 23 exists, the court may award exemplary damages in an amount not exceeding twice any award 24 made under [certain other provisions].” Cal. Civ. Code § 3426.3. Although the statute reserves 25 for “the court” the option of awarding exemplary damages, courts have repeatedly held that the 26 Seventh Amendment guarantees litigants in federal court the right to a jury determination of 27 exemplary damages. See Trandes Corp., v. Guy F. Atkinson Co., 996 F.2d 655, 666 (4th Cir. 1992) 1 (affirming district court’s submission of punitive damages to jury, even though state’s trade secrets 2 statute reserved punitive damages award for the court); see also Cap. Sols., LLC v. Konica Minolta 3 Bus. Sols. U.S.A., Inc., 695 F. Supp. 2d 1149, 1154 (D. Kan. 2010) (“[A]n award of punitive damages, 4 including the amount of the award, has traditionally been a task for the jury; thus, under the required 5 Seventh Amendment historical analysis, the right to a jury attaches not only to the issue of a plaintiff's 6 entitlement to punitive damages, but also to the amount of such damages.”) The Court therefore finds 7 that evidence of Abramowitz’s wealth is admissible and should be presented to the jury. And as for 8 the issue of whether proof of punitive damages should be separately presented to the jury after liability 9 is established, the parties expressly agreed that “bifurcation or separate trials of specific issues is 10 neither feasible nor desired.” Joint Pre-Trial Statement 18, ECF No. 364. Accordingly, Mr. 11 Abramowitz’s motion is DENIED. 12 E. Defendant’s Motion in Limine No. 5 to Exclude Palantir’s Second Amended Trade Secret Disclosure 13 Abramowitz moves to exclude the admission of Palantir’s Second Amended Trade Secret 14 Disclosure (the “Disclosure”) under Rules 403, 703, and 802 of the Federal Rules of Evidence. 15 Def.’s MIL No. 5, ECF No. 360. Abramowitz argues that the Disclosure is inadmissible hearsay, 16 is unfairly prejudicial, and creates a risk of jury confusion about what information Abramowitz 17 had at the time of the alleged trade secret misappropriation. Id. at 2-3. Palantir does not oppose 18 Abramowitz’s motion, so long as the Court excludes the admission of earlier iterations of the trade 19 secret disclosures as Palantir requested in its Motion in Limine No. 2. See Pl.’s Opp’n MIL No. 5, 20 ECF No. 390. 21 The Court’s analysis regarding the non-operative trade secret disclosures, discussed above 22 in reference to Plaintiff’s Motion in Limine No. 2, applies with equal force to the Disclosure. And 23 having excluded the superseded disclosure, Palantir does not object. The Disclosure is therefore 24 inadmissible. Abramowitz’s motion GRANTED. 25 // 26 // 27 Il. ORDER For the foregoing reasons, IT IS HEREBY ORDERED that: e Plaintiff's Motion in Limine No. 1 is DENIED. ° e Plaintiff's Motion in Limine No. 2 is GRANTED. e Plaintiff's Motion in Limine No. 3 is DENIED. ° e Plaintiff's Motion in Limine No. 4 is DEFERRED. ° e Plaintiff's Motion in Limine No. 5 is DENIED. ’ e Defendant’s Motion in Limine No. | is DENIED. ° e Defendant’s Motion in Limine No. 2 is DENIED. ° e Defendant’s Motion in Limine No. 3 is DENIED. 8 e Defendant’s Motion in Limine No. 4 is DENIED. e Defendant’s Motion in Limine No. 5 is GRANTED. Dated: November 7, 2022 ham tn) 14 BETH LABSON FREEMAN 3 5 United States District Judge 16

18 19 20 21 22 23 24 25 26 27 28